Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Biomea Fusion, Inc. (NASDAQ: BMEA) was given a new $10.00 price target on by analysts at Oppenheimer Holdings Inc..
Biomea Fusion Announces Leadership Transition